The summary below gives an overview of important additions and changes MPR has made to its drug database through the end of August. The chart below provides highlights of key monograph updates made this month (not an inclusive list).

Click on the name of the drugs to view the full monographs on eMPR.com.

Key: D=Dosing, IND=Indication, ITX=Interactions, CI=Contraindications,
W/P=Warnings/Precautions, ADR=Adverse Reactions,
HS=How Supplied, MFR=Manufacturer Change

DRUG NAME  UPDATES
(Click on drug name to go to MPR monograph.)   D  IND ITX CI W/P ADR HS MFR
ACTOPLUS MET (Metformin, pioglitizone) X X X   X X    
ACTOS (Pioglitazone) X X     X X    
CUBICIN (Daptomycin)   X X   X X X  
DUETACT (Pioglitazone, glimepiride) X X X   X X    
LAMICTAL ODT (Lamotrigine)         X X    
PERCOCET (Acetominophen, oxycodone) X              
REMICADE (Infliximab)     X          
SIMPONI (Golimumab)     X   X X    
SOMATULINE DEPOT (Lanreotide) X       X      
TEKAMLO (Aliskiren, amlodipine)     X   X      
TEKTURNA (Aliskiren)     X   X      
XELJANZ (Tofacitinib) X   X   X      
ZESTORETIC (Hydrochlorothiazide, lisinopril)   X X X X X    
ZESTRIL (Lisinopril) X     X X X    
Review more drug monograph updates